By Sphera’s Editorial Team | September 28, 2020

Bring Your Quality Risk Management Strategy into the Future

In industries like life sciences and pharmaceuticals, the quality risk management journey is never-ending. These businesses are exposed to profound risk in daily operations, complicated by the need to control intellectual property and deliver essential products to consumers, such as medical treatments and vaccines.

Global life sciences and pharmaceutical organizations are also subject to complex quality compliance standards and regulations, including the International Organization for Standardization (ISO) standards, the International Council for Harmonization of Technical Requirements for Pharmaceuticals and Human Use (ICH) guidelines, and the new European Union Medical Device Regulations (MDR). However, compliance is simply the price of admission in today’s business environment. To stay competitive, global organizations not only need to be compliant, but they also need to strive toward proactive, risk-based decision-making.

Learn more. Download the whitepaper.